Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Eva Segelov
Director of Oncology
Professor Eva Segelov was appointed as the Professor and Director of Oncology at Monash Health and Monash University in February 2017. She is an Honorary Associate of the NHMRC Clinical Trials Centre, Sydney Medical School and Honorary Professor at Shanghai Jiatong University; previously Associate Professor at the University of New South Wales (UNSW) and Senior Medical Oncologist at St Vincent’s Hospital, Sydney. She is a recognised national and international expert in the fields of gastrointestinal cancer, neuroendocrine tumours and breast cancer, with a 20 year history of management of patients in a multidisciplinary setting. As Deparment Head at Monash Health, she oversees a very large Clinical Trials programme with >260 Oncology trials from Phase 1-IV. Professor Segelov is an active member of the Australian Gastrointestinal Trials Group (AGITG), where she is a Board Member and Convenor of the Annual Scientific Meeting. She is Chair of the Gastrointestinal Group of the Clinical Oncological Society of Australia (COSA). In 2016 she was nominated as a European Society of Medical Oncology (ESMO) faculty member for the CUP, Endocrine Tumours, and Others group; ESMO 2019 Scientific Sub-Committee member for Neuroendocrine cancer; co-Track Chair of Gastrointestinal Cancer for the 2017 ESMO Asia Annual Scientific Meeting and co-founder of the Commonwealth Neuroendocrine Tumour Society (CommNETS), an international research collaborative. . She is an Associate Editor of Journal of Global Oncology (American Society of Clinical Oncology). Professor Segelov has led multiple national and international oncology clinical trials, including international investigator-initiated studies. Her research interests relate to translational studies of targeted therapies in defined subpopulations to increase benefit and reduce the toxicity of cancer treatments. She has published over 80 articles, expert reviews, and book chapters and is a frequent invited speaker at national and international conferences. She is a panel member of the 2018 L'Oréal-UNESCO For Women in Science Jury. Professor Segelov has a particular interest in professional development using innovative learning techniques and has developed the Seminal Advances Preceptorship in Cancer courses, now being run through Monash University. She was awarded the UNSW Vice Chancellors Award for Teaching Excellence in 2006. Professor Segelov heads a colorectal translational research laboratory at Monash University, specializing in interrogating clinical trial biospecimens. The laboratory has wide collaborations with current projects investigating biomarkers for aspirin sensitivity as an adjuvant therapy for colorectal cancer; evaluating a ct-DNA biomarker for colorectal cancer recurrence; investigating the role of dendritic cells in colorectal cancer and examining novel drug therapies.

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter